1. Targeting Cancer Stem Cells to Overcome Chemoresistance
   Toni Nunes et al, 2018, International Journal of Molecular Sciences CrossRef
2. Osteosarcoma and Metastasis
   Gaohong Sheng et al, 2021, Frontiers in Oncology CrossRef
3. Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS
   Fabiola Fernandes Heredia et al, 2014, Leukemia Research CrossRef
4. A role of WT1 in cell division and genomic stability
   Jayasha Shandilya et al, 2015, Cell Cycle CrossRef
5. Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines
   Michela Rossi et al, 2023, Archives of Biochemistry and Biophysics CrossRef
6. Nanobiomaterial-based delivery of drugs in various cancer therapies
   Ashok Kumar Pandurangan et al, 2016, Nanobiomaterials in Cancer Therapy CrossRef
7. MAD2 Expression in Ovarian Carcinoma: Different Expression Patterns and Levels among Various Types of Ovarian Carcinoma and Its Prognostic Significance in High-Grade Serous Carcinoma
   Po Eun Park et al, 2013, Korean Journal of Pathology CrossRef
8. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays
   Hao Shen et al, 2018, International Journal of Molecular Medicine CrossRef
9. BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma
   Tara Byrne et al, 2018, International Journal of Gynecologic Cancer CrossRef
10. The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses
    Tara Byrne et al, 2017, Oncotarget CrossRef
11. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions
    Concetta Schiano et al, 2019, Expert Review of Clinical Immunology CrossRef
12. Mad2 Checkpoint Gene Silencing Using Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles in Non-Small Cell Lung Cancer Model
    Ana Vanessa Nascimento et al, 2014, Molecular Pharmaceutics CrossRef
13. Structure–Biological Function Relationship Extended to Mitotic Arrest-Deficient 2-Like Protein Mad2 Native and Mutants-New Opportunity for Genetic Disorder Control
    Speranta Avram et al, 2014, International Journal of Molecular Sciences CrossRef
14. A review on RNAi therapy for NSCLC: Opportunities and challenges
    Vignesh Kumar et al, 2021, WIREs Nanomedicine and Nanobiotechnology CrossRef
15. Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma
    Fei Chen et al, 2016, Hematology CrossRef